Chemours Co. Stock News

Chemours Company has underperformed the Russell 2000 and other material stocks in 2024, with negative returns of 36% on a YTD basis. Even though the current quarter is unlikely to be the greatest on account of seasonal issues, we are choosing to be cautiously optimistic on CC now. CC's most profitable division by far -Thermal & Specialized Solutions, is driving topline growth again, as regulato...

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Pricing of Private Offering of $600,000,000 of 8.000% Senior Notes Due 2033.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2033.

The Chemours Company (NYSE:CC ) Q3 2024 Earnings Call Transcript November 4, 2024 8:00 AM ET Company Participants Brandon Ontjes - VP of IR Denise Dignam - President and CEO Shane Hostetter - CFO Conference Call Participants Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Mike Leithead - Barclays Vincent Andrews - Morgan Stanley Laurence Alexander - Jefferies John Roberts - Mizuho Has...

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Third Quarter 2024 Results and Outlines Refreshed Corporate Strategy.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Fourth Quarter Dividend.

Wolfspeed rallied due to a $750 million investment from Apollo Global Management, despite high short interest and bearish sentiment. SolarEdge Technologies faces significant competition and high inventory levels, making it a potential tax-loss selling candidate. Moderna's stock is under pressure due to declining Covid-19 vaccine demand and weakened profitability, suggesting it should be sold.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2024 Earnings Release and Webcast Conference Call.